Drugs

Order of the Supreme Court regarding ART drugs for people living with HIV/AIDS, 24/02/2025

Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …

SC wants cost-based drug pricing regime to stay

The Supreme Court has given the government a week to frame a final pharma pricing policy, failing which the apex court may pass an interim order in public interest. A Bench, headed by Justice G S Singhvi, posted the matter for next hearing on October 9. In an observation, the …

Concern over market-based mechanism to control drug prices

The All-India Chemists and Distributors’ Federation has expressed displeasure at the method proposed by the Group of Ministers to fix the cost of 348 drugs that have recently been brought under the National List of Essential Medicines. AICDF president Kailash Gupta said: “The method recommended by the GOM in fixing …

Altering the primal environment: Health effects associated with assisted reproductive technologies

When Darine El-Chaar began her residency in obstetrics and gynecology at the University of Ottawa five years ago, she grew curious about the potential health repercussions of assisted reproductive technologies (ART), the catchall term for procedures used to help couples artificially conceive a child. ART involves surgically removing eggs from …

Comparison of essential drug list in a rural secondary care hospital in South India with Indian & World Health Organization list 2011

Fixed drug combinations are a major marketing strategy in India but it can compromise the rational use of medicines. In this study we compared the fixed drug combinations and dosage forms in the hospital pharmacy before and after introducing the essential drug list. We also compared the Hospital Essential Drug …

Global tuberculosis report 2012

India, China, Russian Federation and South Africa have almost 60% of the world's cases of multi-drug-resistant tuberculosis reveals this 17th WHO report on tuberculosis that provides a comprehensive assessment of the TB epidemic & its prevention with data from 204 countries. This is the seventeenth global report on tuberculosis (TB) …

NGO to Challenge Market-linked Drug Pricing in Supreme Court

The move could further delay implementation of the policy All India Drug Action Network, the non-government organisation that forced the government to regulate prices of 348 essential drugs, is set to challenge the pricing mechanism finalised by a group of ministers in the Supreme Court. The move could further delay …

New Policy to Cost Pharma Cos 1,300 Cr

The drug pricing formula recommended by a ministerial panel will erode the revenues of pharmaceutical companies by about . 1,300 crore, according to market research firm IMS Health. Among these companies, Ranbaxy, GlaxoSmithKline, Dr Reddy’s and Novartis would be affected the most, it added. The panel on Thursday decided to …

Replicating Tamil Nadu's drug procurement model

Most states are attempting to copy the Tamil Nadu Medical Services Corporation's model of centralised tendering and purchase of drugs. A study of the Kerala Medical Services Corporation and Odisha's State Drug Management Unit shows that imitating the original model without factoring in the local context and building up the …

Pharma GoM Finalises Pricing Policy for 348 Drugs

Recommends prices of 348 drugs be fixed at weighted average price of brands with more than 1% market share. The Group of Ministers (GoM) set up to determine the country’s drug pricing policy will recommend that retail prices of 348 essential drugs be fixed at the weighted average price of …

Govt to put price limit on 348 essential drugs

New Delhi: India will, for the first time, put a cap on the maximum price at which essential drugs can be sold in the country. These include commonly used AIDS and cancer drugs, besides a horde of painkillers, TB drugs, sedatives, lipid lowering agents and steroids. In a landmark decision, …

GoM wants market-based pricing for 348 drugs

The Group of Ministers set up to propose a new drug-pricing policy on Thursday recommended a market-based mechanism to regulate prices of 348 essential medicines. The GoM has proposed to cap prices of these medicines at the weighted average price of drugs with a minimum of one per cent market …

Cuba tests prostate cancer vaccine

Cuban scientists said they have concluded the second round of the clinical trial of a potential vaccine against prostate cancer. Urologist Ranfis Rodriguez Monday said 56 patients, who were vaccinated in two hospitals, showed a remarkable improvement in their condition, reported Xinhua. A decrease in specific prostate tumour antigens was …

Accumulation of pharmaceuticals, enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in Central Mexico

Irrigation with wastewater releases pharmaceuticals, pathogenic bacteria, and resistance genes, but little is known about the accumulation of these contaminants in the environment when wastewater is applied for decades. We sampled a chronosequence of soils that were variously irrigated with wastewater from zero up to 100 years in the Mezquital …

Govt to introduce compensation guidelines for drug trial deaths

Aiming to secure the safety of people involved in drug trials in the country, the Government is in the process of framing guidelines for awarding compensation in cases of death during these trials. The hallmark of the new guidelines would be the fixing of minimum mandatory compensation to be paid …

A bitter pill

The Novartis case highlights the need for innovation in the public interest. The Supreme Court has commenced final hearings on a case brought before it by the Swiss pharmaceutical company, Novartis. The case disputes the denial of a patent on Novartis’s anti-cancer drug Glivec. Novartis’s position is that incentives to …

Retraction record rocks community

One of the biggest purges of the scientific literature in history is finally getting under way. After more than a decade of suspicion about the work of anaesthesiologist Yoshitaka Fujii, formerly of Toho University in Tokyo, investigations by journals and universities have concluded that he fabricated data on an epic …

Open source drug discovery in practice: A case study

Open source drug discovery offers potential for developing new and inexpensive drugs to combat diseases that disproportionally affect the poor. The concept borrows two principle aspects from open source computing (i.e., collaboration and open access) and applies them to pharmaceutical innovation. By opening a project to external contributors, its research …

India Drops Plan to Drag US to WTO

India has decided to put on hold its plan to drag the US to the World Trade Organisation for raising the cost of work visas, hoping to resolve the issue bilaterally with the new government after the US presidential elections in November. “We have dropped plans of taking US to …

Tighter regulations likely for vitamin supplement market

New Delhi The government is planning to tighten the regulatory landscape of the R4,500-crore vitamins and neutraceuticals market in the country. Different arms of government — the drug regulator, Drug Controller General of India (DCGI), and the food regulator, Food Safety and Standards Authority of India (FSSAI) — are taking …

Interpol wants to join the ‘fake drugs’ battle, Indian government fights shy

New Delhi The International Cri-minal Police Organisation, popularly known as Interpol, wants to assist the Indian government in its effort to clamp down on the alleged ‘fake drugs’ network in the country. While the France-headquartered agency wants New Delhi and India’s generic drug companies to sign up for the Interpol …

  1. 1
  2. ...
  3. 46
  4. 47
  5. 48
  6. 49
  7. 50
  8. ...
  9. 151

IEP content by date loading...
IEP child categories loading...